Citations

Showing 10 of 108152 citations.

PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis
Wang, Dingzhi , Fu, Lingchen, Wei, Jie , Xiong, Ying , DuBois, Raymond N.

Mayo Clinic

Cancer Research | June 25, 2019 | Volume: 79 | Issue: 17 | Pages: 4480-4490

10.1158/0008-5472.can-19-0384 | PMID 31239272 Get It

Abstract The nuclear hormone receptor peroxisome proliferator-activated receptor delta (PPARδ) is a ligand-dependent transcription factor involved in fatty acid metabolism, obesity, wound healing, inflammation, and cancer. Although PPARδ has been shown to promote intestinal adenoma formation and growth, the molecular mechanisms underlying the contribution of PPARδ to colorectal cancer remain unclear. Here, we demonstrate that activation of PPARδ induces expansion of colonic cancer stem cells (CSC) and promotes colorectal cancer liver metastasis by binding to the Nanog promoter and enhancing Nanog expression. Moreover, PPARδ mediated the effect of a high-fat diet in promoting liver metastasis and induction of colonic CSC expansion. Our findings uncover a novel role of dietary fats in colorectal cancer metastasis and reveal novel mechanisms underlying PPARδ-mediated induction of CSCs and those responsible for the contribution of dietary fats to colorectal cancer progression. These findings may provide a rationale for developing PPARδ antagonists to therapeutically target CSCs in colorectal cancer. Significance: These findings show that PPARδ contributes to colorectal cancer metastasis by expanding the CSC population, indicating that antagonists that target PPARδ may be beneficial in treating colorectal cancer.
Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy
Koller, Emily J., Cruz, Elsa Gonzalez De La, Machula, Timothy A., Ibanez, Kristen R. , Lin, Wen-Lang, Williams, Tosha , Riffe, Cara J., Ryu, Daniel, Strang, Kevin H., Janus, Christopher , Golde, Todd E. , Giasson, Benoit I. , Chakrabarty, Paramita , Liu, Xuefei , Dickson, Dennis W.

Mayo Clinic

Human Molecular Genetics | June 25, 2019 | Volume: 28 | Issue: 19 | Pages: 3255-3269

10.1093/hmg/ddz151 | PMID 31261380 Get It

Abstract Understanding the biological functions of tau variants can illuminate differential etiologies of Alzheimer’s disease (AD) and primary tauopathies. Though the end-stage neuropathological attributes of AD and primary tauopathies are similar, the etiology and behavioral outcomes of these diseases follow unique and divergent trajectories. To study the divergent physiological properties of tau variants on a uniform immunogenetic background, we created somatic transgenesis CNS models of tauopathy utilizing neonatal delivery of adeno-associated viruses expressing wild-type (WT) or mutant tau in non-transgenic mice. We selected four different tau variants—WT tau associated with AD, P301L mutant tau associated with frontotemporal dementia (FTD), S320F mutant tau associated with Pick’s disease and a combinatorial approach using P301L/S320F mutant tau. CNS-targeted expression of WT and P301L mutant tau results in robust tau hyperphosphorylation without tangle pathology, gradually developing age-progressive memory deficits. In contrast, the S320F variant, especially in combination with P301L, produces an AD-type tangle pathology, focal neuroinflammation and memory impairment on an accelerated time scale. Using the doubly mutated P301L/S320F tau variant, we demonstrate that combining different mutations can have an additive effect on neuropathologies and associated co-morbidities, possibly hinting at involvement of unique functional pathways. Importantly, we also show that overexpression of wild-type tau as well as an FTD-associated tau variant can lead to cognitive deficits even in the absence of tangles. Together, our data highlights the synergistic neuropathologies and associated cognitive and synaptic alterations of the combinatorial tau variant leading to a robust model of tauopathy.
Little Finger Injury - Football
Abadin, Andre A., Cicciaro, John, DeMatas, Kristina, Rosario‐Concepción, Raúl A. , Pujalte, George

Mayo Clinic

Medicine & Science in Sports & Exercise | June 25, 2019 | Volume: 51 | Issue: 6S | Pages: 630-632

10.1249/01.mss.0000562387.69467.08 Get It

Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease
Kasanuki, Koji , Brennan, Rebecca, Vargas, Emily , Soto, Alexandra I., Murray, Melissa E. , Koga, Shunsuke , Ross, Owen A. , Valentino, Rebecca R. , Brennan, Rebecca R, Labbé, Catherine, Vargas, Emily R, Koga, Shunsuke , Ross, Owen A , Murray, Melissa E , Heckman, Michael G. , Labbé, Catherine , Dickson, Dennis W.

Mayo Clinic

Movement Disorders | June 25, 2019 | Volume: 34 | Issue: 9 | Pages: 1325-1332

10.1002/mds.27773 | PMID 31234228 Get It

AbstractBackgroundGenetic variation at the microtubule‐associated protein tau locus is associated with clinical parkinsonism. However, it is unclear as to whether microtubule‐associated protein tau H1 subhaplotypes are associated with the burden of neuropathological features of Lewy body disease.ObjectivesTo evaluate associations of microtubule‐associated protein tau haplotypes with severity of Lewy body pathology and markers of SN neuronal loss in Lewy body disease cases.MethodsFive hundred eighty‐five autopsy‐confirmed Lewy body disease cases were included. Six microtubule‐associated protein tau variants (rs1467967, rs242557, rs3785883, rs2471738, rs8070723, and rs7521) were genotyped to define common microtubule‐associated protein tau haplotypes. Lewy body counts were measured in five cortical regions. Ventrolateral and medial SN neuronal loss were assessed semiquantitatively. Nigrostriatal dopaminergic degeneration was quantified by image analysis of tyrosine hydroxylase immunoreactivity in the dorsolateral and ventromedial putamen.ResultsThe common microtubule‐associated protein tau H2 haplotype did not show a strong effect on pathological burden in Lewy body disease. The rare H1j haplotype (1.3%) was significantly associated with a lower dorsolateral putaminal tyrosine hydroxylase immunoreactivity (and therefore greater dopaminergic degeneration) compared to other microtubule‐associated protein tau haplotypes (P = 0.0016). Microtubule‐associated protein tau H1j was also nominally (P ≤ 0.05) associated with a lower ventromedial putaminal tyrosine hydroxylase immunoreactivity (P = 0.010), but this did not survive multiple testing correction. Other nominally significant associations between microtubule‐associated protein tau H1 subhaplotypes and neuropathological outcomes were observed.ConclusionsA rare microtubule‐associated protein tau H1 subhaplotype (H1j) may be associated with more severe putaminal dopaminergic degeneration in Lewy body disease cases. Microtubule‐associated protein tau H1j has been associated previously with an increased risk of PD, and therefore our exploratory findings provide insight into the mechanism by which H1j modulates PD risk. © 2019 International Parkinson and Movement Disorder Society
Physical Exercise, APOE E4 Genotype And Cognitive Trajectories: The Mayo Clinic Study Of Aging
Syrjanen, Jeremy A. , Vassilaki, Maria , Trautwein, Sandra , Barisch‐Fritz, Bettina , Boes, Klaus, Wöll, Alexander , Kremers, Walter K. , Petersen, Ronald C. , Kremers, Walter K , Krell‐Roesch, Janina , Machulda, Mary M. , Mielke, Michelle M. , Knopman, David S. , Geda, Yonas E.

Mayo Clinic

Medicine & Science in Sports & Exercise | June 25, 2019 | Volume: 51 | Issue: 6S | Pages: 473-473

10.1249/01.mss.0000561924.66614.c4 Get It

NCAA Division I Women’s Cross Country Consumes Adequate Energy Midseason Following Nutrition Education Seminars
Mallard, Jared A., Beckmann, Kelsey M., Orange, Terrance, Coyle, Kevin, Conway, Kara L., Wight, Jeff T., Hooper, David R. , Sáenz, Catherine , Pujalte, George G.A.

Mayo Clinic

Medicine & Science in Sports & Exercise | June 25, 2019 | Volume: 51 | Issue: 6S | Pages: 892-892

10.1249/01.mss.0000563167.51753.d8 Get It

A Critical Analysis of Medicare Claims for Otolaryngology Procedures
Youssef, Stephanie J. , Vyas, Krishna S.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | June 25, 2019 | Volume: 161 | Issue: 6 | Pages: 929-938

10.1177/0194599819858584 | PMID 31237824 Get It

ObjectiveThis study was performed to outline and analyze the overall Medicare landscape with respect to otolaryngologists and beneficiaries, services, and reimbursements.MethodsThis is a retrospective analysis of publicly available Medicare utilization and payment data for all otolaryngologists in facility and nonfacility practice settings who provided services to Medicare beneficiaries between January 1, 2012, and December 31, 2016.ResultsIn 2016, a total of $701,195,375 was distributed to 8572 otolaryngology physician providers for 815 unique Healthcare Common Procedure Coding System codes for 13,942,536 procedure claims. Of specialty care, otolaryngology ranks 20th among 54 subspecialties for total Medicare payments. The average number of services coded per provider was 1627. The average otolaryngologist was paid $81,800.67. Thirty‐two percent of otolaryngologists did not receive reimbursement for services from Medicare in 2016.DiscussionIn 2016, the most significant contributors to Medicare payments to otolaryngologists were large‐scale, low‐cost events that are relatively short procedures done in clinic. Utilization of nasal endoscopy was up trending from 2012 to 2016. Some of the Current Procedural Terminology codes with the greatest discrepancies between submitted charge and Medicare payment among nonfacility otolaryngology providers are more involved than simple office procedures.Implications for PracticeIt is increasingly valuable for physicians to know factors that affect reimbursement for procedures and operations in different settings and to be aware of the trends in variation in their specialty. Otolaryngologists should communicate with policy makers in efforts toward sustainable reimbursement models.
One Size Does Not Fit All—The Implications of Using Body Mass Index in Critical Care Outcomes Research
Patel, Jayshil J. , Mundi, Manpreet S.

Mayo Clinic

Critical Care Medicine | June 25, 2019 | Volume: 47 | Issue: 7 | Pages: e611-e612

10.1097/ccm.0000000000003733 | PMID 31205090 Get It

Evaluation of Associations of Alzheimer’s Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures
Sakae, Nobutaka, Vargas, Emily , Carrasquillo, Minerva M. , Murray, Melissa E. , Kasanuki, Koji , Ertekin‐Taner, Nilüfer , Younkin, Steven G. , Vargas, Emily R, Murray, Melissa E , Heckman, Michael G. , Carrasquillo, Minerva M. , Dickson, Dennis W.

Mayo Clinic

Journal of Alzheimer's Disease | June 25, 2019 | Volume: 70 | Issue: 3 | Pages: 659-666

10.3233/jad-190451 | PMID 31256143 Get It